AMN New products
DESCRIPTION
What is RegenPRP ?
-----------------------------------The platelet concentrate prepared with this RegenLab technology provides an autologous reservoir of growth factors.
- Platelets are key factors in tissue repair mechanisms. They provide essential growth factors, such as FGF, PDGF, TGF-β, EGF, VEGF, IGF, which are involved in stem cell migration, differentiation and proliferation. Platelets also stimulate fibroblasts and endothelial cells to induce the deposition of new extracellular matrix and neovascularisation, respectively. The platelets are concentrated from the patient’s own blood.
- Plasma contains many factors essential for cell survival including nutrients, vitamins, hormones,electrolytes, growth factors (such as IGF and HGF), and proteins. Among the plasma proteins, the molecules vital for the coagulation process and fibrin polymer formation will serve as a scaffold for cell migration and new tissue generation
"RegenPRP could be considered as an effective procedure for facial rejuvenation as it induces collagen production in the dermis."
The simple, safe and efficient point of care preparation of autologous platelet-rich plasma
TECHNOLOGY PLATFORM FOR STANDARDISED
AUTOLOGOUS REGENERATIVE MEDICINE
The simple, safe and efficient point of care preparation of autologous platelet-rich plasma
TECHNOLOGY ADVANTAGES
• User-independent standardised preparation
• Minimum volume of blood required
• Safe closed-circuit system
• Mechanical isolation of PRP using a biologically inert separator gel after a 5-minute centrifugation
• Reversible anticoagulation with a pharmaceutical grade solution of sodium citrate at pH 7
• Minimal learning curve and ease of use
• Operationally and clinically efficient process
• Facilitates and streamlines routine practice
BIOLOGICAL ADVANTAGES
• RegenPRP is standardised, leucocyte reduced and easily reproducible. reduced and easily reproducible.
(RegenLab specific separating gel technology guarantees minimal variability)
• Platelet recovery > 80%
• High platelet quality.
(Viable & functional platelets)
• Full plasma recovery.
(No loss of plasma growth factors and fibrinogen)
• Leucocyte reduced PRP.
(Depletion of 96.7% of pro-inflammatory granulocytes, leaving mainly lymphocytes and monocytes)
• Virtually no red blood cells.
(Depletion of ~ 99.7% of erythrocytes)
SCIENTIFIC ADVANTAGES
• Demonstrated safety and efficacy
• Evidence-based outcomes for numerous therapeutic indications.
• Large number of clinical studies, with over 200 publications.
• User-independent standardised preparation
• Minimum volume of blood required
• Safe closed-circuit system
• Mechanical isolation of PRP using a biologically inert separator gel after a 5-minute centrifugation
• Reversible anticoagulation with a pharmaceutical grade solution of sodium citrate at pH 7
• Minimal learning curve and ease of use
• Operationally and clinically efficient process
• Facilitates and streamlines routine practice
BIOLOGICAL ADVANTAGES
• RegenPRP is standardised, leucocyte reduced and easily reproducible. reduced and easily reproducible.
(RegenLab specific separating gel technology guarantees minimal variability)
• Platelet recovery > 80%
• High platelet quality.
(Viable & functional platelets)
• Full plasma recovery.
(No loss of plasma growth factors and fibrinogen)
• Leucocyte reduced PRP.
(Depletion of 96.7% of pro-inflammatory granulocytes, leaving mainly lymphocytes and monocytes)
• Virtually no red blood cells.
(Depletion of ~ 99.7% of erythrocytes)
SCIENTIFIC ADVANTAGES
• Demonstrated safety and efficacy
• Evidence-based outcomes for numerous therapeutic indications.
• Large number of clinical studies, with over 200 publications.
TYPE OF REGEN LAB TUBE
